NCT06018480

The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation

NADPH Oxidase Affects on Blood Flow After Administering a High Carbohydrate Meal Pre- and Post-creatine Monohydrate Supplementation.
Florida State University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Endothelial Dysfunction
Drug/Device/Intervention
Creatine Monohydrate
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Florida State University
Location
Tallahassee, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 29, 2023
End date
Apr 01, 2025
Enrollment
10 participants
Primary outcome

Concentrations of reactive oxygen species (ROS),Rate of skeletal muscle blood flow,Flow mediated dilation percentage

Summary

This research study seeks to determine the effects of an enzyme in the human body called
 NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of
 creatine monohydrate, a common sports performance supplement, on blood food and vessel
 function. Participants will undergo two study arms, one in which they consume a high
 carbohydrate meal pre- and post-creatine monohydrate supplementation and one in which they
 will consume a high carbohydrate meal pre- and post-placebo supplementation. Blood flow and
 endothelial function will be assessed before and for 4 hours following the consumption of a
 high-carbohydrate meal pre and post-supplementation (creatine monohydrate and placebo).

ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06018480
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06018480 through Pure Global AI's free database. This phase not specified trial is sponsored by Florida State University and is currently Recruiting. The study focuses on Endothelial Dysfunction. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.